Skip to main content
SpringerLink
Log in

Anti-ctla-4-monoclonal antibody

Severe immune related colitis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Subrahmanyam PB, et al. Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients. Journal for ImmunoTherapy of Cancer 6: No. 1, 6 Mar 2018. Available from: URL: http://doi.org/10.1186/s40425-018-0328-8 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anti-ctla-4-monoclonal antibody. Reactions Weekly 1697, 43 (2018). https://doi.org/10.1007/s40278-018-44599-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44599-y

Search

Navigation